Punjab government issues public advisory amid spike in COVID-19 cases
The advisory issued on Friday says, "Due to slight rise in COVID-19 cases in some parts of the country, a precautionary advisory is being issued. Thought the situation in the state of Punjab is under control and the health system is fully prepared, still, citizens are advised to follow basic safety measures to help prevent the spread of disease.''
Issuing the Dos, the advisory noted: 'Individuals should cover their mouth and nose while coughing or sneezing—using a handkerchief, tissue, or the inside of the elbow. In case of symptoms such as fever, cough, or difficulty in breathing, it is advised to wear a mask and consult a doctor immediately.
Listing the don'ts the advisory advised to avoid crowded or poorly ventilated places, especially if you have health problems and do not touch your face without washing hands, do not spit in public and avoid self-medication for respiratory symptoms.
The advisory follows a noticeable surge in infections across the state, particularly in Ludhiana, which has emerged as the current hotspot.
Two persons, one a 69-year-old woman, who was undergoing treatment at PGIMER in Chandigarh and another, a 39-year-old man, who was admitted to Government Medical College Hospital, Sector 32 of Chandigarh succumbed to the infection. Both were natives of Ludhiana.
According to the Punjab Health Department, the active COVID-19 cases in the state has risen from just 12 a week ago to over 35, touching 60 this year.
The has been a steep rise seen in Ludhiana, which has reported 23 new cases, attributed in part to ongoing political gatherings due to the Ludhiana (West) assembly by-poll as political leaders of various parties and the party workers are busy with campaign works
Sources said that both the pre-existing medical conditions and the recent travel history, have made the situation more vulnerable to complications.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
5 hours ago
- News18
Breaking India's Non Communicable Diseases Chain: A Call For Freedom From Chronic Diseases
Noncommunicable diseases silently claim millions of Indian lives each year, but with early action, prevention, and awareness, the country can break this deadly chain. Every Independence Day, we drape ourselves in the tricolour, sing the anthem, and remind each other how hard freedom was won. But for millions of Indians living with chronic illnesses, true freedom remains out of reach. Cardiovascular disease, cancer, chronic respiratory illnesses, and diabetes collectively called noncommunicable diseases (NCDs) now account for 62% of all deaths in Southeast Asia, according to the World Health Organization. Every year, nine million people in the region die from these conditions, many before their 70th birthday. Dr Sabine Kapasi, CEO at Enira Consulting, Founder of ROPAN Healthcare, and UN Advisor shares all you need to know: The threat is not only in the staggering numbers, it lies in the way these diseases silently take root. Poor diets, inactivity, pollution, and genetic predisposition create a slow, invisible chain of damage. By the time symptoms are recognised, it is often too late to reverse them. Yet, most premature NCD deaths are preventable. The COVID-19 surge in May 2021 made this painfully clear. Obesity, diabetes, and other chronic conditions sharply increased the risk of death. Thousands who might have survived the virus did not because their bodies were already weakened by diseases they had been silently managing for years. Globally, NCDs claim 41 million lives annually, including 14 million people aged 30 to 70. Without urgent action, the WHO warns this could rise to 55 million by 2030. For India, the stakes are also economic: reports estimate a loss of $4.58 trillion by 2030 due to NCD-related costs, with heart disease and mental health conditions making up the largest share. But there is hope. India's preventive health ecosystem is growing—startups, government programmes, and grassroots health workers are joining forces. Metabolic trackers, Oura Rings, Tata 1mg dashboards, and workplace health screenings are already spotting risks early. If we sustain this momentum, by 2047 we could win freedom from preventable diseases, redefining independence as the ability to live well. The Government's '75/25" initiative aims to bring care to 75 million people with hypertension and diabetes by December 2025. As of March 2025, treatment had reached 42 million people for hypertension and 25 million for diabetes 89% of the target. This progress is encouraging, but numbers alone cannot dismantle stigma, misinformation, or health neglect. Encouragingly, AIIMS Nagpur and UNICEF Maharashtra are now addressing an often-ignored crisis: NCDs in children. The 2019 Comprehensive National Nutrition Survey revealed alarming trends among children as young as five. Experts warn of a growing risk among children aged 5–9 and adolescents aged 10–19, proof that prevention must begin far earlier than we think. The fight against NCDs is no longer a public health issue alone, it is a national movement. Just as we once came together to win our political freedom, we must now unite to secure the freedom to live long, healthy, and fulfilling lives. view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
NDTV
5 hours ago
- NDTV
ADHD Medicines Reduce Suicide, Crime Risks In Sweeping Study
Drugs to treat attention deficit hyperactivity disorder were linked to a reduced risk of suicidal behavior, substance misuse and criminality in the first research of its kind. The findings come amid increasing debate around whether ADHD is being over-diagnosed and therefore over-treated with drugs like Ritalin. The research published in the British Medical Journal on Wednesday did not investigate whether patients are being accurately diagnosed, but it does provide evidence supporting medical treatment. ADHD is characterized by difficulties with concentration and impulse control. Roughly 5% of children and 2.5% of adults are estimated to have the condition, which is also associated with an increased risk of substance misuse and self-harm. The researchers wanted to test whether the risk changed with medication. The study design was meant to closely mirror a randomized clinical trial, considered the gold standard of research. The scientists looked at health registry data from almost 150,000 patients newly diagnosed with ADHD in Sweden. At a two-year follow-up, they found that patients taking medicine had a 17% reduction in suicidal behavior and a 15% drop in substance misuse. They also found declines in the risk for criminality and transport accidents. When looking at the recurrence of these behaviors, there were also benefits linked to the medication. While the trial cannot show direct causation and could be confounded by factors such as ADHD severity, it provides doctors with vital evidence showing that drugs can address and reduce important risks, according to one of the authors. "These data should inform clinical guidelines, policies and current debates," said Samuele Cortese, a professor of child and adolescent psychiatry at the University of Southampton. The benefit was greater for patients taking stimulant medications than non-stimulants in the study. Stimulants include drugs like Novartis AG's Ritalin, while non-stimulants include Eli Lilly & Co.'s Strattera. The study results echo other similar conclusions, but "the large sample size, use of a national registry, and more sophisticated analysis give greater confidence in these results that findings aren't explained by something else other than medication use," said Adam Guastella, a clinical psychologist who works at Sydney Children's Hospital at Westmead and the University of Sydney's Brain and Mind Center. He was not involved in the research. Prescriptions in England for ADHD medicines have increased 18% year on year since the Covid-19 pandemic, according to research published in the BMJ Mental Health this year. The surge is believed to be linked to greater awareness of the condition.
Economic Times
6 hours ago
- Economic Times
AI and machine learning: Driving a global tech revolution worth trillions
Artificial Intelligence (AI) and Machine Learning (ML) have transformed from a futuristic vision to the fundamental forces behind the world's major tech-empowered industrial revolution. From financial markets to other industries such as healthcare, retail, and manufacturing, AI and ML are no longer supplementary technologies. They are the engines powering innovation, productivity, and economic growth globally. Artificial intelligence is the most prominent commercial opportunity in the rapidly evolving world, with the potential to contribute $15.7 trillion to the global economy by 2030, as indicated by a recent report by PwC. As per the report published by Grand View Research, machine learning, a subset of AI, is anticipated to expand at a compound annual growth rate (CAGR) of over 36% between 2024 and 2030. Transforming global industries at unprecedented speed AI and ML are having an impact on many industries globally. These technologies are transforming business operations, making them more efficient and allowing data-driven decisions in various business domains. It is changing business models and generating unprecedented innovation globally. How? Healthcare AI-powered diagnostic equipment is leading to an earlier and more accurate diagnosis of diseases such as cancer and heart disease. It is assisting in early disease detection and increasing survival chances considerably. Predictive analytics assists hospitals in determining the patients at risk, lowering the rate of readmission by more than 25%. Artificial intelligence is changing the delivery of healthcare services in developed and developing countries, including drug invention and remote discovery. For example, it was discovered using BenevolentAI's AI platform, which analysed vast biomedical datasets to predict how existing drugs could interact with Covid-19 pathways. The AI suggested Baricitinib as a potential medicine within days, something that traditionally could have taken months, helping accelerate clinical trials and eventual emergency approvals. Finance Fraud detection tools empowered with artificial intelligence monitor billions of transactions in real time, and automated trading algorithms make transactions in a matter of seconds. JPMorgan Chase report points out that over $150 million is saved annually through AI-enabled systems. Global consumer financial services are also being secured, liberalised, and personalised through AI-driven banking services. Retail and e-commerce AI-powered predictive analytics can forecast customer purchasing habits with a predicted 90 percent accuracy. It enables retailers to predict demand and customise inventory to ensure the most sales are made, and reduce wastage of stock. These technologies allow dynamic pricing, filtering product recommendations according to the tastes and preferences of customers, acceleration of order placements, easier shopping experiences, and increased satisfaction among customers in both online and offline stores. Manufacturing AI-enabled predictive maintenance systems help factories by predicting breakdowns of equipment before they actually occur, up to a 60% improvement in equipment lifetime alongwith reduction in downtime. This not only saves millions of operational costs, but also improves worker safety. AI-empowered robotics is also becoming involved in complicated and risky operations, increasing productivity and product quality globally. The global AI market size, valued at $196.6 billion in 2024, is projected to surpass $1.8 trillion by 2030. North America currently leads in adoption, but Asia-Pacific is the fastest-growing region, with investments in AI startups increasing year-on-year. Agriculture AI is also poised to play a pivotal role in addressing global challenges. Climate scientists are leveraging AI to model weather patterns and optimise renewable energy grids, potentially reducing carbon emissions by up to 10% annually (Source: In developing economies, AI is enabling leapfrog growth. Empowering people and boosting economies through the AI & ML revolution While automation raises concerns of job loss, the statistics showcase a clearer picture. World Economic Forum estimations show that by the end of 2025, AI will create 97 million new jobs in fields such as AI engineering, data science, as compared to the 85 million jobs already existing in the market (Source: Artificial intelligence development companies are spending heavily on employee upskilling in response to this change. Google AI training already has more than 3 million learners worldwide, and IBM has committed to skilling up to 30 million people by 2030 globally. " Every technological revolution disrupts the job market, but it also creates new opportunities that didn't exist before, " said Naveen Khanna, CEO of Octal IT Solution, which is a leading mobile app development company. " The AI era is no different, and the winners will be those who adapt fastest. " Navigating the ethics and regulatory guidelines of AI innovation With the faster AI adoption rate, ethical and regulatory systems are taking centre stage. The AI Act of the European Union is projected to become fully operative by 2026. It will establish the first complete regulatory framework for the worldwide use of AI. In the meantime, major economies and nations, are implementing specific policies towards AI and machine learning solutions to make it safer and accountable to innovation. A PwC survey revealed that 94% of organizations accepts that they have implemented or planning to implement AI in their business operations as AI ethics will be critical to building trust with stakeholders. Issues related to biased algorithms of AI, data-related privacy, and transparency still exist, yet widely used responsible AI principles are being adopted by companies. Gartner reports that by 2027, organizations will implement small, task-specific AI models, with usage volume at least 3 times more than those of general-purpose large language models (LLMs). Driving the future: AI and ML as the ultimate game changer The AI and ML will become fundamental to business competitiveness in this decade, as the internet did in earlier periods. Early adopters are already reaping exponential gains, while latecomers risk being left behind. Octal IT Solutions is also committed to providing AI-powered solutions that have delivered up to 45% operational efficiency improvements and 30% cost reductions for enterprises. " AI is no longer about replacing humans; it's about augmenting their capabilities ," said Arun Goyal, MD, Octal IT Solution, one of the leading voices in AI innovation. "This shift is empowering businesses to make better decisions, streamline operations, and open entirely new markets that didn't exist a decade ago." AI and ML are no longer optional; they are the driving forces shaping the next era of global innovation and economic growth. Businesses, industries, and nations that embrace this transformation today will define the competitive landscape of tomorrow. Disclaimer - The above content is non-editorial, and TIL hereby disclaims any and all warranties, expressed or implied, relating to it, and does not guarantee, vouch for or necessarily endorse any of the content.
